Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An investigator initiative trial of STNM01 by an Endoscopic Submocal Injection to Investigate the Efficacy in Patients with Ulcerative Colitis

Next Previous
X
Search
Trial Profile

An investigator initiative trial of STNM01 by an Endoscopic Submocal Injection to Investigate the Efficacy in Patients with Ulcerative Colitis

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs GUT 1 (Primary)
  • Indications Crohn's disease; Ulcerative colitis
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 17 Oct 2023 Results (n=5) assessing efficacy of add-on submucosal injections of GUT-1 presented at the 31st United European Gastroenterology Week
    • 12 May 2021 According to a Mitsubishi Tanabe Pharma Corporation media release, MTPC decided to discontinue the STNM01 project as sufficient effects were not confirmed.
    • 12 May 2021 Status changed from recruiting to discontinued, according to a Mitsubishi Tanabe Pharma Corporation media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top